抵抗性膜性腎臓病におけるリトキシマブに対する治療反応に影響を与える要因
Lianzi Ma1, Li Yang1, Jing Zheng1
1Nephrology Department, Nanfang Hospital, Guangzhou, 510515, People's Republic of China.
Drug design, development and therapy
|August 27, 2025
まとめ
リトゥキシマブは,耐火性膜性腎不全 (MN) を効果的に治療する. アルブミン,クレアチニン,eGFRのような重要なバイオマーカーは,治療の成功を予測し,この治療法の患者の選択を助けます.
科学分野:
- 腎臓科
- 免疫学
- 薬理学について
背景:
- 耐火性膜性腎不全 (MN) は,持続的なタンパク質尿と標準的な免疫抑制剤に対する耐性により,重大な課題を提示する.
- 治療反応の予測要因を特定することは,患者の治療結果を最適化するために極めて重要です.
研究 の 目的:
- 耐火性MNにおけるリトキシマブの有効性に影響を与える要因を特定する.
- 臨床的および生化学的予測因子を決定する.
- リトゥキシマブ治療の患者選択基準を精査する.
主な方法:
- バイオプシーで確認された耐火性MN患者160人がリトキシマブ (375 mg/ m2) を受けた.
- 人口統計,臨床パラメータ,生化学マーカーを含むベースラインデータを分析した.
- 単変数,多変数ロジスティック回帰,およびROC曲線分析が採用されました.
主要な成果:
- 応答した患者 (n=113) は,血清アルブミン,eGFR,血清クレアチニン,24時間尿中のタンパク質,PLA2R- Abの値が非応答者 (n=47) に比べて有意に高かった.
- これらのマーカーは,独立した反応の予測因子として識別された.
- 治療効果を予測する高精度 (AUC 0. 99) を達成した.
結論:
- リトゥキシマブは耐火性MNに有効です.
- 特定の臨床的および生化学的マーカーは,治療の成功を正確に予測します.
- 検証されたバイオマーカーの組み合わせは 個別化された治療決定とリソースの割り当てを助けます
さらに関連する動画
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
3.6K
関連する概念動画
01:17Factors Affecting Renal Clearance: Renal Impairment
157
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
157
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
28
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
28
01:11Renal Failure: Dose Adjustments
153
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
153
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
227
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
227